Mohamad Rawas-Qalaji
Overview
Explore the profile of Mohamad Rawas-Qalaji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shindo S, Nakamura S, Rawas-Qalaji M, Heidari A, Pastore M, Okamoto M, et al.
bioRxiv
. 2024 Sep;
PMID: 39282284
Significance Statement: The mechanosensitive Ca channel Piezo1 plays important regulatory roles in a variety of cellular activities. RANKL-mediated OC-genesis requires permissive co-stimulatory signal from ITAM receptors, such as OSCAR and...
2.
Ishii T, Ruiz-Torruella M, Yamamoto K, Yamaguchi T, Heidari A, Pierrelus R, et al.
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628440
It is well known that Semaphorin 4D (Sema4D) inhibits IGF-1-mediated osteogenesis by binding with PlexinB1 expressed on osteoblasts. However, its elevated level in the gingival crevice fluid of periodontitis patients...
3.
Shindo S, Savitri I, Ishii T, Ikeda A, Pierrelus R, Heidari A, et al.
Int J Mol Sci
. 2022 Mar;
23(6).
PMID: 35328359
Effects of the antiosteoblastogenesis factor Semaphorin 4D (Sema4D), expressed by thrombin-activated platelets (TPs), on osteoblastogenesis, as well as osteoclastogenesis, were investigated in vitro. Intact platelets released both Sema4D and IGF-1....
4.
Manni M, Heinrich V, Buchan G, OBrien J, Uvalle C, Cechova V, et al.
Sci Rep
. 2021 Sep;
11(1):17788.
PMID: 34493738
Bile acid profiles are altered in obese individuals with asthma. Thus, we sought to better understand how obesity-related systemic changes contribute to lung pathophysiology. We also test the therapeutic potential...
5.
Bafail R, Rawas-Qalaji M, Rawas-Qalaji M, Aodah A
Drug Dev Ind Pharm
. 2019 Jul;
45(10):1617-1623.
PMID: 31353966
AS FDSTs will provide an accessible alternative for AS autoinjector (ATROPEN), and a noninvasive first-aid antidote for the treatment of organophosphate (OP) poisoning and reduce the number of fatalities due...
6.
Aodah A, Rawas-Qalaji M, Bafail R, Rawas-Qalaji M
AAPS PharmSciTech
. 2019 Jun;
20(6):229.
PMID: 31227930
Atropine sulfate (AS) fast-disintegrating sublingual tablets (FDSTs) were tested for AS sublingual permeation's feasibility as a potential alternative dosage form to treat organophosphates (OP) toxicity. More than 12,000 OP pesticide...